Curatis Holding AG (SWX:CURN)

Market Cap	52.42M
Revenue	n/a
Net Income	n/a
Shares Out	4.99M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	452
Average Volume	990
Open	10.10
Previous Close	10.30
Day's Range	10.10 - 10.25
52-Week Range	5.00 - 18.20
Beta	n/a
RSI	51.97
Earnings Date	n/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hy...

• Industry: Pharmaceutical Preparations
• CEO: Roland Rutschmann
• Employees: 7
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: CURN